Task: Answer the multiple-choice question.
Question: Which drug exhibits a -22.036% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccc(Cl)cc2)c1-c1ccc2c(c1)OCO2
b O=[N+]([O-])c1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCOCC2)cc1
Answer: b. O=[N+]([O-])c1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=[N+]([O-])c1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCOCC2)cc1
O=[N+]([O-])c1ccc(S(=O)(=O)NCC(c2cccnc2)N2CCOCC2)cc1
N-(2-morpholin-4-yl-2-pyridin-3-ylethyl)-4-nitrobenzenesulfonamide